Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$4.96 +0.33 (+7.13%)
Closing price 07/15/2025
Extended Trading
$4.96 0.00 (-0.10%)
As of 04:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BNR vs. EUDA, SERA, QIPT, NAKA, KDLY, ATPC, CORBF, OPGN, PIII, and BDSX

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), Agape ATP (ATPC), Global Cord Blood (CORBF), OpGen (OPGN), P3 Health Partners (PIII), and Biodesix (BDSX). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs. Its Competitors

Burning Rock Biotech (NASDAQ:BNR) and EUDA Health (NASDAQ:EUDA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

EUDA Health has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -45.41%. EUDA Health's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-45.41% -38.33% -25.34%
EUDA Health N/A N/A N/A

Burning Rock Biotech has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, EUDA Health has a beta of -0.04, meaning that its stock price is 104% less volatile than the S&P 500.

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 4.3% of EUDA Health shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

EUDA Health has lower revenue, but higher earnings than Burning Rock Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$70.67M0.76-$47.49M-$1.89-2.62
EUDA Health$4.01M29.92-$15.36MN/AN/A

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 1 articles in the media. Burning Rock Biotech's average media sentiment score of 1.89 equaled EUDA Health'saverage media sentiment score.

Company Overall Sentiment
Burning Rock Biotech Very Positive
EUDA Health Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

EUDA Health beats Burning Rock Biotech on 7 of the 11 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$53.37M$2.41B$14.96B$9.30B
Dividend YieldN/A1.43%2.71%4.02%
P/E Ratio-2.6230.9627.8719.60
Price / Sales0.7633.5045.5574.26
Price / CashN/A40.9625.4927.56
Price / Book0.675.926.315.56
Net Income-$47.49M$33.05M$195.98M$257.73M
7 Day Performance34.05%-0.17%-0.49%0.97%
1 Month Performance29.50%11.44%6.26%10.70%
1 Year Performance-31.11%37.94%24.46%15.67%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
1.4687 of 5 stars
$4.96
+7.1%
N/A-26.0%$53.37M$70.67M-2.621,390Positive News
EUDA
EUDA Health
1.28 of 5 stars
$3.33
-1.5%
N/A-17.5%$125.59M$4.01M0.002
SERA
Sera Prognostics
0.5189 of 5 stars
$2.42
-2.8%
N/A-56.5%$93.81M$80K-2.57120
QIPT
Quipt Home Medical
3.1564 of 5 stars
$1.73
-2.8%
$2.85
+64.7%
-36.0%$77.33M$245.91M-8.241,200
NAKA
KindlyMD
N/A$12.04
-5.6%
N/AN/A$76.88M$2.72M-15.64N/A
KDLY
Kindly MD
N/A$12.75
-2.8%
N/A+412.5%$76.78M$2.47M-16.56N/AGap Up
ATPC
Agape ATP
0.5576 of 5 stars
$1.40
+2.6%
N/A-65.6%$68.01M$1.29M-2.3240
CORBF
Global Cord Blood
N/A$0.55
-62.1%
N/AN/A$66.85M$196.12M0.001,200Gap Down
OPGN
OpGen
N/A$5.02
+6.1%
N/A+49.4%$50.54M$2.67M0.00100Gap Down
PIII
P3 Health Partners
3.3801 of 5 stars
$6.40
+0.3%
$16.25
+153.9%
-76.5%$45.86M$1.49B-0.14500Positive News
BDSX
Biodesix
4.0573 of 5 stars
$0.28
+1.5%
$1.75
+534.5%
-81.5%$39.81M$71.32M-0.95220Positive News

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners